Stay updated on Pembro & HER2Bi-ACT for Met CRPC Clinical Trial

Sign up to get notified when there's something new on the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The screenshots show only minor UI/layout differences with no changes to core study information (title, conditions, eligibility criteria, primary outcomes, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T02:14:53.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    3%
    Check dated 2025-10-06T15:55:40.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T09:53:14.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A minor patch updates the revision from v3.0.1 to v3.0.2 and removes the Back to Top element; core content and key data appear unchanged.
    Difference
    0.2%
    Check dated 2025-09-14T23:55:33.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T20:37:20.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while numerous related medical topics and terms have been removed, including references to pembrolizumab and various cancer-related subjects.
    Difference
    3%
    Check dated 2025-08-31T12:59:02.000Z thumbnail image

Stay in the know with updates to Pembro & HER2Bi-ACT for Met CRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page.